HMGB1 and neoplasm: The interaction of HMGB1 protein released from dying tumor cells with TLR4 on DCs was required for the cross-presentation of tumor antigens and the promotion of tumor specific cytotoxic T-cell responses[10,11,24], which are selectively involved in the cross-priming of anti-tumor T lymphocytes in vivo [25,26].